Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07127016 · ClinicalTrials.gov registry record · NA

Mindfulness in Nonflaccid Facial Paralysis

A NA study, sponsored by Wake Forest University Health Sciences.

Not yet
Registry status
NA
Development phase
24
Enrollment target

NCT07127016: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.

NCT07127016 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07127016, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.

NOT YET RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this study is to learn more about how mindfulness techniques can help reduce anxiety, depression and body image disturbance as well as improve synkinesis in individuals with non-flaccid facial paralysis.

Primary Outcome

15 items rated on a 5-point Likert scale where 1 corresponds to the lowest level of function and 5 corresponds to the highest level of function. The items are categorized into 6 domains: facial movement, facial comfort, oral function, eye comfort, lacrimal control and social function with each domain being scored out of a total of 100 where 0 is the worst possible score to 100 being the best. The mean derived from all domains will determine the total score (out of 100).

Interventions

  • BEHAVIORAL Mindfulness Sessions
  • BEHAVIORAL No Mindfulness Sessions

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2026-07
Est. Completion 2027-01
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What is known before NCT07127016 opens enrollment

NCT07127016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Mindfulness Sessions is the first listed.

NCT07127016 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07127016 about?

NCT07127016 is a clinical study titled "Mindfulness in Nonflaccid Facial Paralysis". The purpose of this study is to learn more about how mindfulness techniques can help reduce anxiety, depression and body image disturbance as well as improve synkinesis in individuals with non-flaccid facial paralysis.

What is the current status of trial NCT07127016?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-07. Estimated completion is 2027-01.

What interventions are being tested in trial NCT07127016?

The interventions under investigation include: Mindfulness Sessions (BEHAVIORAL), No Mindfulness Sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT07127016?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07127016's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07127016, the US trial registry maintained by the National Library of Medicine. NCT07127016 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.